Brooks O'neil analyst

Currently out of the existing stock ratings of Brooks O'neil, 148 are a BUY (94.87%), 8 are a HOLD (5.13%).

Brooks O'neil

Work Performance Price Targets & Ratings Chart

Analyst Brooks O'neil, has had 50.16% of price targets met with an average potential upside of 33%, reached in 268 days on average. Previously, Brooks O'neil worked at LAKE STREET.

Brooks O'neil has documented 321 price targets and ratings displayed on 34 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on HROW, Harrow Health at 04-Mar-2026.

Wall Street Analyst Brooks O'neil

Analyst best performing recommendations are on SMLR (SEMLER SCIENTIFIC).
The best stock recommendation documented was for SMLR (SEMLER SCIENTIFIC) on 7/30/2018. The price target of $22 was fulfilled within 3 days with a profit of $4.5 (25.71%), with a performance score of 85.71.

Average potential price target upside

ATEC Alphatec Holdings CSII Cardiovascular Systems JYNT The Joint Corp KIN Kindred Biosciences LMAT LeMaitre Vascular OPCH Option Care Health SMLR Semler Scientific SRDX SurModics SRGA Surgalign Holdings TNDM Tandem Diabetes Care AMEH Apollo Medical Holdings ARAY Accuray DPLO Diplomat Pharmacy DYNT Dynatronics ELMD Electromed HROW Harrow Health INFU InfuSystems Holdings SIEN Sientra RCEL Avita Medical Ltd ICAD icad inc AUGX Augmedix STRM Streamline Health Solutions MODV ModivCare PIII P3 Health Partners NUWE Nuwellis AMN AMN Healthcare Services AORT Artivion CCRN Cross Country Healthcare CRY CryoLife LFMD LifeMD VMD Viemed Healthcare MDXG MiMedx Group LFVN BEAT Heartbeam

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Dec-2020

$20

$12.93 (182.89%)

$24

5 days ago
(12-Nov-2026)

Buy Since 27-Jul-2026

$8.5

$1.43 (20.23%)

$16

14 days ago
(03-Nov-2026)

0/3 (0%)

$1.03 (13.79%)

Buy Since 18-Oct-2020

$10

$2.93 (41.44%)

$13

19 days ago
(29-Oct-2026)

7/11 (63.64%)

$2.96 (42.05%)

241

Buy Since 24-Aug-2021

$12

$4.93 (69.73%)

$14

19 days ago
(29-Oct-2026)

23/30 (76.67%)

$4.96 (70.45%)

422

Buy Since 31-Jul-2024

$8

$0.93 (13.15%)

$12

19 days ago
(29-Oct-2026)

3/5 (60%)

$0.96 (13.64%)

188

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?